Frost Gregory Ian 4
4 · HALOZYME THERAPEUTICS INC · Filed Feb 5, 2013
Insider Transaction Report
Form 4
Frost Gregory Ian
DirectorVP and Chief Scientific Off.
Transactions
- Exercise/Conversion
Common Stock
2013-02-02+11,312→ 3,566,643 total - Exercise/Conversion
Common Stock
2013-02-02+4,737→ 3,571,380 total
Footnotes (2)
- [F1]Represents net settlement for the vesting of 19,213 shares of a restricted stock unit award granted in February 2012. Upon vesting of these units on February 2, 2013, the reporting person received a settlement of 11,312 shares of Halozyme common stock. 7,901 shares were withheld as payment for minimum statutory tax withholding requirements.
- [F2]Represents net settlement for the vesting of 7,500 shares of another restricted stock unit award granted in February 2012. Upon vesting of these units on February 2, 2013, the reporting person received a settlement of 4,737 shares of Halozyme common stock. 2,763 shares were withheld as payment for minimum statutory tax withholding requirements.